CD39, in conjunction with CD73, mainly functions on creating an immunosuppressive microenvironment for cancer via extracellular adenosine triphosphate (ATP) to ADP, AMP and adenosine conversion [4]. This evidence concerns the gene ENTPD1 and cancer.